Latest Remuneration News

Helia Group appoints Mark Senkevics as CEO from December 2026 and Craig Ward as CFO from July 2026, outlining detailed remuneration and transition plans amid ongoing leadership changes.

Heavy Rare Earths Limited has appointed Jason Barnett as Managing Director and CEO, aiming to leverage his extensive mining experience as the company advances its critical minerals projects and prepares for a maiden drilling campaign.

Lindian Resources has cancelled 13 million performance rights held by a former executive chairman, sparking uncertainty as a potential $10 million claim looms.

Swift TV Ltd has secured $2.33 million through a $1.9 million placement and a $430,000 debt conversion, boosting its capacity to deliver contracted deployments and expand recurring revenue streams.

Bounty Oil & Gas NL has issued a prospectus offering over 632 million new options to eligible investors as part of a broader recapitalisation, potentially raising $6.3 million if exercised.

Amaero Ltd secured strong shareholder approval for its US re-domiciliation schemes and a director option grant at virtual meetings held on 5 June 2026.

Findi Limited has transitioned Stephen Benton to Non-Executive Chairman while Nicholas Smedley refocuses on the Indian business and TSI IPO plans. A strategic review aims to sharpen capital allocation and progress the Payments Bank licence.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Conrad Asia Energy appoints Peter Botten as Executive Chairman and initiates CEO search amid transition to gas producer with first gas targeted for late 2027.

Elanor Investors Group appoints David McNamara as CEO, signaling a leadership shift following a balance sheet recapitalisation and strategic reset. The Board also sees key transitions with Tony Fehon moving to a non-executive role and Su Kiat Lim stepping down.

Opthea Limited resumes ASX trading as it pivots to develop OPT-302 for lymphangioleiomyomatosis, outlining a disciplined 18-month staged clinical program backed by A$31.2 million in cash.

Bison Resources has appointed Tim Mackellar as CEO, leveraging his senior mining and capital markets experience to drive exploration and development efforts.